News Articles on Cepheid

Cepheid Reports 2009 Third Quarter Results

    --  Total product sales of $40.8 million in the third quarter of 2009,
        compared to $42.4 million in the third quarter of 2008.  By i
http://www.bioportfolio.com/news/Cepheid-Reports-2009-Third-Quarter.html  - Wednesday October 28 2009
Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
SUNNYVALE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Nicol
http://www.bioportfolio.com/news/Cepheid-Expands-Leadership-Team-With-Appointment.html  - Tuesday October 13 2009
Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast
SUNNYVALE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results f
http://www.bioportfolio.com/news/Cepheid-Schedules-2009-Third-Quarter-Financial.html  - Tuesday October 13 2009
Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast
SUNNYVALE, Calif., July 9 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its second qua
http://www.bioportfolio.com/news/Cepheid_Schedules_2009_Second_Quarter_Financial.html  - Thursday July 9 2009
New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
SUNNYVALE, Calif., June 24 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today noted that a new article, Evaluation of Universal Antenatal S
http://www.bioportfolio.com/news/New_England_Journal_of_Medicine_Study_Highlights.html  - Wednesday June 24 2009
Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)
  



Oncology Test Further Highlights Broad Market Applicability of GeneXpert System

SUNNYVALE, Calif.
http://www.bioportfolio.com/news/Cepheid_Announces_European_Release_of_Improved.html  - Wednesday June 17 2009
Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
New Capabilities Will Further Extend GeneXpert System Technology Advantages

SUNNYVALE, Calif., June 10 /PRNewswire-FirstCal
http://www.bioportfolio.com/news/Cepheid_Receives_Grant_to_Develop_Ten-Color.html  - Wednesday June 10 2009
Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference
SUNNYVALE, Calif., June 4 /PRNewswire-FirstCall/ --- Cepheid (Nasdaq: CPHD) today announced speaker and program highlights for its symposium, "
http://www.bioportfolio.com/news/Cepheid_Announces_Symposium_Program_for_2009.html  - Thursday June 4 2009
Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
On-Demand Test for Genetic Risk of Thrombosis Improves Time-to-Result over Current Molecular Tests

SUNNYVALE, Calif. and BE
http://www.bioportfolio.com/news/Cepheid_Receives_Health_Canada_License_for.html  - Wednesday June 3 2009
Cepheid Reports 2009 First Quarter Results
                                 Three Months Ended
                                      March 31,
                                  2009  2008 Chang
http://www.bioportfolio.com/news/Cepheid_Reports_2009_First_Quarter.html  - Thursday April 23 2009
Cepheid Schedules Fiscal 2009 First Quarter Financial Results Announcement and Webcast
SUNNYVALE, Calif., April 9 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 
http://www.bioportfolio.com/news/Cepheid_Schedules_Fiscal_2009_First_Quarter.html  - Thursday April 9 2009
Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
Physician Access to Critical Test Results Improved by More Than Twenty-Four Hours Over Conventional Methods

SUNNYV
http://www.bioportfolio.com/news/Cepheid_Receives_Health_Canada_License_for_First.html  - Wednesday March 11 2009
Cepheid Reports Fourth Quarter and Full Year 2008 Results
                         Three Months Ended       Full Year Ended
                             December 31             December 31
                   
http://www.bioportfolio.com/news/Cepheid_Reports_Fourth_Quarter_and_Full_Year_2008.html  - Thursday February 5 2009
Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
    SUNNYVALE, Calif., Jan. 13 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today announced preliminary revenue results for its 2008 fourth
qua
http://www.bioportfolio.com/news/Cepheid_Announces_Preliminary_2008_Fourth_Quarter.html  - Tuesday January 13 2009
Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
    SUNNYVALE, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today announced that Health Canada has issued a medical device
lice
http://www.bioportfolio.com/news/Cepheid_Receives_Health_Canada_License_for_First.html  - Monday November 24 2008
Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
    SUNNYVALE, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today announced the release of Xpert(TM) C. difficile as a
European
http://www.bioportfolio.com/news/Cepheid_Launches_First_On-Demand_Molecular.html  - Monday November 10 2008
Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA
    SUNNYVALE, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD)
today announced the U.S. Food & Drug Administration (FDA) catego
http://www.bioportfolio.com/news/Cepheid_Molecular_Diagnostic_Test_for_Positive.html  - Tuesday November 4 2008
Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
    SUNNYVALE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today noted an announcement from Birmingham Children's Hospita
http://www.bioportfolio.com/news/Results_of_United_Kingdom_MRSA_Surveillance.html  - Monday October 27 2008
Cepheid to Webcast Upcoming Financial Presentations
    SUNNYVALE, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today announced that its executives will be speaking at the
followi
http://www.bioportfolio.com/news/Cepheid_to_Webcast_Upcoming_Financial.html  - Friday August 22 2008
Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
    SUNNYVALE, Calif., July 29 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today introduced its GeneXpert(R) Infinity-48 high-throughput
syste
http://www.bioportfolio.com/news/Cepheid_Introduces_GeneXpert%28R%29_Infinity-48.html  - Tuesday July 29 2008
Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy
    SUNNYVALE, Calif., July 28 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today announced that the State of Victoria has selected
Cepheid&apo
http://www.bioportfolio.com/news/Cepheid_GeneXpert%28R%29_System_and_Xpert%28TM%29_MRSA.html  - Monday July 28 2008
Cepheid Reports Second Quarter Revenue of $42.1 Million
    SUNNYVALE, Calif., July 24 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today reported revenue for the second quarter of 2008 of $42
http://www.bioportfolio.com/news/Cepheid_Reports_Second_Quarter_Revenue_of_%2442.1.html  - Thursday July 24 2008
Cepheid to Webcast Analyst Event
    SUNNYVALE, Calif., July 21 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today invited investors to participate in the Company's Analys
http://www.bioportfolio.com/news/Cepheid_to_Webcast_Analyst.html  - Monday July 21 2008
Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
    SUNNYVALE, Calif., July 14 /PRNewswire-FirstCall/ -- Cepheid
(Nasdaq: CPHD) today announced that it will report financial results for its
fisca
http://www.bioportfolio.com/news/Cepheid_Schedules_Fiscal_2008_Second_Quarter.html  - Monday July 14 2008
Cepheid Management to Present at the 7th Annual Needham Medical Technology and Biotechnology Conference and William Blair's 28th Annual Growth Stock Conference
    SUNNYVALE, Calif., June 4 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD)
announced today that the Company will webcast presentations at the f
http://www.bioportfolio.com/news/Cepheid_Management_to_Present_at_the_7th_Annual.html  - Wednesday June 4 2008
Cepheid Market Reach Extended with Licenses in Canada and Registrations in Mexico
    SUNNYVALE, Calif., June 3 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD)
today announced that Health Canada issued a medical device license f
http://www.bioportfolio.com/news/Cepheid_Market_Reach_Extended_with_Licenses_in.html  - Tuesday June 3 2008